Stuart Therapeutics Announces Start of Patient Enrollment in its Phase 2 Clinical Trial of ST-100 for Dry Eye Disease
/PRNewswire/ -- Stuart Therapeutics, Inc. ("Stuart"), a clinical stage biopharmaceutical company conducting research and development of unique peptide...
Source: prnewswire.com